Page last updated: 2024-11-03

prazosin and Carcinoma, Anaplastic

prazosin has been researched along with Carcinoma, Anaplastic in 3 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonello, A1
Hrelia, P1
Leonardi, A1
Marucci, G1
Rosini, M1
Tarozzi, A1
Tumiatti, V1
Melchiorre, C1
Sakamoto, K1
Kojima, S1
Hokimoto, S1
Ogawa, H1
Cain, DT1
Battersby, I1
Doyle, R1

Other Studies

3 other studies available for prazosin and Carcinoma, Anaplastic

ArticleYear
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
    Journal of medicinal chemistry, 2005, Jan-13, Volume: 48, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antioxidants; Bioche

2005
Pheochromocytoma multisystem crisis with transient stress cardiomyopathy due to ruptured pheochromocytoma.
    BMJ case reports, 2015, Dec-09, Volume: 2015

    Topics: Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenalectomy; Antihypertensive Agents; Breast Neop

2015
Response of dogs with urinary tract obstructions secondary to prostatic carcinomas to the α-1 antagonist prazosin.
    The Veterinary record, 2016, Jan-23, Volume: 178, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Carcinoma; Dog Diseases; Dogs; Male; Prazosin; Pro

2016